[go: up one dir, main page]

IL134538A0 - PROCESSES FOR THE PRODUCTION OF CLASTO-LACTACYSTIN β-LACTONE DERIVATIVES AND ANALOGS AND NOVEL γ-LACTAM CARBOXYLIC ACID DERIVATIVES - Google Patents

PROCESSES FOR THE PRODUCTION OF CLASTO-LACTACYSTIN β-LACTONE DERIVATIVES AND ANALOGS AND NOVEL γ-LACTAM CARBOXYLIC ACID DERIVATIVES

Info

Publication number
IL134538A0
IL134538A0 IL13453898A IL13453898A IL134538A0 IL 134538 A0 IL134538 A0 IL 134538A0 IL 13453898 A IL13453898 A IL 13453898A IL 13453898 A IL13453898 A IL 13453898A IL 134538 A0 IL134538 A0 IL 134538A0
Authority
IL
Israel
Prior art keywords
derivatives
clasto
lactacystin
analogs
novel
Prior art date
Application number
IL13453898A
Other versions
IL134538A (en
Original Assignee
Millennium Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharm Inc filed Critical Millennium Pharm Inc
Publication of IL134538A0 publication Critical patent/IL134538A0/en
Publication of IL134538A publication Critical patent/IL134538A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/282-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/14Preparation of carboxylic acid amides by formation of carboxamide groups together with reactions not involving the carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/72Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
    • C07C235/80Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms having carbon atoms of carboxamide groups and keto groups bound to the same carbon atom, e.g. acetoacetamides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00Compounds containing azido groups
    • C07C247/02Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C247/04Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/675Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
IL13453898A 1997-08-15 1998-08-14 Lactacystin derivatives and pharmaceutical compositions containing the same IL134538A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US91211197A 1997-08-15 1997-08-15
US5584897P 1997-08-15 1997-08-15
US6735297P 1997-12-03 1997-12-03
PCT/US1998/016858 WO1999009006A1 (en) 1997-08-15 1998-08-14 SYNTHESIS OF CLASTO-LACTACYSTIN β-LACTONE AND ANALOGS THEREOF

Publications (2)

Publication Number Publication Date
IL134538A0 true IL134538A0 (en) 2001-04-30
IL134538A IL134538A (en) 2005-11-20

Family

ID=27368920

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13453898A IL134538A (en) 1997-08-15 1998-08-14 Lactacystin derivatives and pharmaceutical compositions containing the same

Country Status (11)

Country Link
EP (1) EP1021407A4 (en)
JP (1) JP2001515064A (en)
KR (1) KR20010022950A (en)
CN (1) CN1271342A (en)
AU (1) AU749857B2 (en)
BR (1) BR9811304A (en)
CA (1) CA2301054A1 (en)
HU (1) HUP0002724A3 (en)
IL (1) IL134538A (en)
NZ (1) NZ503169A (en)
WO (1) WO1999009006A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4322802A (en) 2000-11-16 2002-06-24 Univ California Marine actinomycete taxon for drug and fermentation product dicovery
CA2443813A1 (en) * 2001-04-09 2002-10-17 Allan Christian Shaw Method for identification of proteins from intracellular bacteria
US7176232B2 (en) 2002-06-24 2007-02-13 The Regents Of The University Of California Salinosporamides and methods for use thereof
US7179834B2 (en) 2002-06-24 2007-02-20 The Regents Of The University Of California Salinosporamides and methods for use thereof
JP2005537292A (en) * 2002-07-31 2005-12-08 ヒャリテ−ウニヴェルズィテーツメディジン ベルリン Use of proteasome inhibitors in the treatment of endothelial dysfunction and / or in low-dose proteasome inhibitor therapy
MXPA05013982A (en) 2003-06-20 2006-05-25 Nereus Pharmaceuticals Inc Use of [3.2.0] heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases.
CN1823070A (en) 2003-06-20 2006-08-23 加利福尼亚大学董事会 Salinosporamide and methods of use thereof
US7579371B2 (en) 2004-04-30 2009-08-25 Nereus Pharmaceuticals, Inc. Methods of using [3.2.0] heterocyclic compounds and analogs thereof
EP2025679A3 (en) 2004-04-30 2009-07-08 Nereus Pharmaceuticals, Inc. [3.2.0] Heterocyclic compounds and methods of using the same
BRPI0517135B1 (en) 2004-12-03 2022-04-19 Triphase Research And Development I Corp Compositions and methods for treating neoplastic diseases
BRPI0709474A2 (en) 2006-04-06 2011-07-12 Nerus Pharmaceuticals Inc total synthesis of salinosporamide a and its analogues
US7824698B2 (en) 2007-02-02 2010-11-02 Nereus Pharmaceuticals, Inc. Lyophilized formulations of Salinosporamide A
US8394816B2 (en) 2007-12-07 2013-03-12 Irene Ghobrial Methods of using [3.2.0] heterocyclic compounds and analogs thereof in treating Waldenstrom's Macroglobulinemia
BRPI0909661A2 (en) 2008-03-07 2015-08-11 Nereus Pharmaceuticals Inc Compound and chemical synthesis and compound formation or preparation methods
CA2723465A1 (en) 2008-05-12 2009-11-19 Nereus Pharmaceuticals, Inc. Proteasome inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0863913A4 (en) * 1995-08-21 2001-04-11 Univ Duke METHOD FOR INCREASING THE DENSITY OF AN ANTIGEN ON A CELL HAVING AN ANTIGEN

Also Published As

Publication number Publication date
EP1021407A4 (en) 2001-07-04
JP2001515064A (en) 2001-09-18
HUP0002724A2 (en) 2001-02-28
NZ503169A (en) 2001-12-21
IL134538A (en) 2005-11-20
EP1021407A1 (en) 2000-07-26
HUP0002724A3 (en) 2001-04-28
AU8906298A (en) 1999-03-08
AU749857B2 (en) 2002-07-04
BR9811304A (en) 2001-11-13
WO1999009006A1 (en) 1999-02-25
CA2301054A1 (en) 1999-02-25
KR20010022950A (en) 2001-03-26
CN1271342A (en) 2000-10-25

Similar Documents

Publication Publication Date Title
ZA9710038B (en) Method for the production of levulinic acid and its derivatives
SG43676A1 (en) Process for the production of acetic acid
SG86467A1 (en) Process for the production of acetic acid
SG66356A1 (en) Process for production of acrylic acid
ZA973002B (en) Carboxylic acid derivatives medicaments comprising these compounds their use and processes for their production
HUP9902645A3 (en) Fused-ring carboxylic acid derivatives
IL134538A0 (en) PROCESSES FOR THE PRODUCTION OF CLASTO-LACTACYSTIN β-LACTONE DERIVATIVES AND ANALOGS AND NOVEL γ-LACTAM CARBOXYLIC ACID DERIVATIVES
SI0770687T1 (en) Process for the preparation of nicotinic acid amide
PL329240A1 (en) Novel derivatives of carboxylic acid, their production and application
IL127634A0 (en) Process for the production of a-tocopherol esters
HUT75640A (en) Novel quinolone carboxylic acid derivatives
HUP9800343A3 (en) Process for the production of clavulanic acid and/or salts thereof
EP0632011A3 (en) Process for the preparation of alcoxy carboxylic acid esters.
SG46150A1 (en) Process for the production of carboxylic acid anhydrides
HUP9801403A3 (en) Carboxylic acid derivatives preparation process
ZA981472B (en) Process for the manufacture of carboxylic acids
AU4259493A (en) Process for producing hydroxyalkane carboxylic acid amides
HUP9802329A3 (en) Carboxylic acid derivatives
ZA961843B (en) Process for the preparation of esters of stilbenedi-carboxylic acid
IL125787A (en) Process for the preparation of heteroarylcarboxylic amides and esters, and novel isopropyl-2-chloropyrid-6-yl carboxylate
GB9603422D0 (en) Process for the production of a carboxylic acid
SG45344A1 (en) Process for the hydrocycarbonylation of lactones
HUP9900923A3 (en) Process for the synthesis of vinyl-sulfenic acid derivatives
AU1780800A (en) Process for the preparation of aromatic carboxylic acid amides
IL119731A0 (en) A process for the production of erythorbic acid

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees